Patients in the iPAH group had a significantly higher percentage of T cells CD8+/PD-1+ than the controls (p < 0.001) and CTD-PAH patients (p < 0.001). The gene discussed is CD8A; the disease is idiopathic pulmonary arterial hypertension.